Thrivent Financial for Lutherans grew its stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 15.9% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 340,297 shares of the company's stock after purchasing an additional 46,673 shares during the period. Thrivent Financial for Lutherans owned approximately 0.39% of HealthEquity worth $32,652,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Arcadia Investment Management Corp MI acquired a new stake in shares of HealthEquity in the 4th quarter worth approximately $26,000. Smartleaf Asset Management LLC boosted its position in HealthEquity by 34.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock worth $37,000 after purchasing an additional 98 shares in the last quarter. Proficio Capital Partners LLC acquired a new stake in HealthEquity in the fourth quarter valued at $39,000. UMB Bank n.a. increased its position in shares of HealthEquity by 65.6% in the fourth quarter. UMB Bank n.a. now owns 414 shares of the company's stock valued at $40,000 after buying an additional 164 shares in the last quarter. Finally, Skandinaviska Enskilda Banken AB publ raised its stake in shares of HealthEquity by 1,934.8% during the 4th quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company's stock worth $45,000 after buying an additional 445 shares during the last quarter. 99.55% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of equities research analysts recently commented on the stock. Wells Fargo & Company increased their price objective on shares of HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a research note on Wednesday, February 26th. Royal Bank of Canada raised their price objective on shares of HealthEquity from $100.00 to $105.00 and gave the stock an "outperform" rating in a research note on Tuesday, December 10th. KeyCorp reduced their target price on HealthEquity from $120.00 to $110.00 and set an "overweight" rating on the stock in a research note on Monday. JMP Securities boosted their price target on HealthEquity from $105.00 to $107.00 and gave the stock a "market outperform" rating in a report on Tuesday, December 10th. Finally, Raymond James raised HealthEquity from an "outperform" rating to a "strong-buy" rating and decreased their price objective for the company from $120.00 to $115.00 in a research note on Tuesday. One research analyst has rated the stock with a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of "Buy" and a consensus target price of $113.31.
Get Our Latest Analysis on HQY
HealthEquity Trading Down 0.1 %
Shares of HQY stock traded down $0.13 during trading hours on Tuesday, hitting $90.19. 2,054,483 shares of the company were exchanged, compared to its average volume of 697,297. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $115.59. The firm has a fifty day moving average of $104.67 and a 200 day moving average of $95.84. The firm has a market cap of $7.80 billion, a PE ratio of 82.74, a PEG ratio of 1.60 and a beta of 0.62. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51.
Insiders Place Their Bets
In other news, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the transaction, the director now directly owns 78,219 shares of the company's stock, valued at $8,704,992.51. The trade was a 6.85 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. 2.20% of the stock is currently owned by insiders.
HealthEquity Company Profile
(
Free Report)
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Featured Stories

Before you consider HealthEquity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.
While HealthEquity currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.